A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric
Clinical trial NCT05315830 · UNKNOWN
Trial details
- NCT number
- NCT05315830
- Sponsor
- The First Affiliated Hospital of Bengbu Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2023-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.